Q32 Bio Presents New Preclinical Data at the International Society of Nephrology Frontiers Meeting Demonstrating the Therapeutic Potential of ADX-097
/PRNewswire/ -- Q32 Bio, a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, today announced that the...
Stefan Wawersik Shelia Violette Sarah Sutton Brendan Burns International Society Of Nephrology Directed Factorh Targeting Delivers Potent
Source: prnewswire.com